Integrated Drug Discovery Projects Like – FTEs, FFS

    We have specialized team with broad array of experience to preparing NCEs molecules with high quality specification.

    Synthesized capability up to mg scale to gm scale and kg scale.

    Deliver the compounds with complete characterization data like… 1H NMR, Mass, LC-MS, HPLC etc.

    We have wide range of chemistry expertise like…. heterocyclic chemistry, peptide chemistry, carbohydrate chemistry, chiral chemistry, fragment library chemistry etc.

    Integrated drug discovery projects often involve various components and arrangements to efficiently advance drug development. Two common terms used in this context are FTEs (Full-Time Equivalents) and FFS (Fee-for-Service). Let’s break down what these terms mean:

    FTEs refer to the number of full-time employees or resources dedicated to a specific project. In the context of drug discovery, FTEs are often used to describe the level of staffing allocated to a project. For example, if a pharmaceutical company has ten scientists working full-time on a drug discovery project, this would be equivalent to ten FTEs.

    FFS is a payment model where a service provider charges fees for specific services rendered. In the context of drug discovery, FFS can be used when a pharmaceutical company contracts with external service providers (such as contract research organizations or CROs) for specific tasks or services related to drug discovery. Instead of hiring additional full-time staff, they pay fees for the services they need on a project-by-project basis. This approach offers flexibility and cost control.

    Integrated drug discovery projects may involve a combination of both FTEs and FFS arrangements. For instance, a pharmaceutical company may have its in-house scientists (FTEs) working on certain aspects of the project while outsourcing specific tasks or expertise (FFS) to CROs or other specialized service providers to optimize resources and accelerate drug development.

    The choice between FTEs and FFS depends on various factors, including the project’s complexity, the company’s internal capabilities, budget constraints, and the need for specialized expertise. Pharmaceutical companies often make strategic decisions on staffing and outsourcing to efficiently navigate the drug discovery process while managing costs and timelines.